go to medicines.ie homepage
Font Size
Search for:  
select
  Advanced Search

Novartis Ireland Limited
Beech House, Beech Hill Office Campus, Clonskeagh, Dublin 4,
Telephone: +353 1 2601255
Fax: +353 1 2601263
Medical Information e-mail: medinfo.dublin@novartis.com
Patient Information Leaflet last updated on medicines.ie: 09/09/2009
PIL Aclasta 5 mg solution for injection

When a pharmaceutical company changes an SPC or PIL, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 09/09/2009 and displayed until Current
Reasons for adding or updating:
  • Change to, or new use for medicine
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 23/01/2009 and displayed until 09/09/2009
Reasons for adding or updating:
  • Changes to therapeutic indications
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 30/10/2007 and displayed until 23/01/2009
Reasons for adding or updating:
  • Changes to therapeutic indications
Updated on 11/01/2007 and displayed until 30/10/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contraindications
Updated on 22/07/2005 and displayed until 11/01/2007
Reasons for adding or updating:
  • New PIL for new product

Document Links

 
  View all medicines
from this company
View Document
Bookmark and Share

Active Ingredients

 
  Zoledronic Acid Anhydrous